The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2020.26.11.1412
Abstract: BACKGROUND: Individuals with sickle cell disease (SCD) suffer from recurrent catastrophic pain crises that are often managed by opioid analgesics. Being adherent to hydroxyurea has been associated with decreased health care resource use for pain;… read more here.
Keywords: adherent hydroxyurea; opioid use; hydroxyurea; opioid prescriptions ... See more keywords